昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

已收盘 01-09 16:08:35

26.100

+1.880

+7.76%

最高26.200	最低23.820	成交量977.27万
今开24.500	昨收24.220	日振幅9.83%
总市值195.49亿	流通市值31.06亿	总股本7.49亿
成交额2.45亿	换手率8.21%	流通股本1.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":26.1,"timestamp":1767946115005,"preClose":24.22,"halted":0,"volume":9772738,"delay":0,"floatShares":118995206,"shares":749000000,"eps":0.1116529602057918,"marketStatus":"已收盘","change":1.88,"latestTime":"01-09 16:08:35","open":24.5,"high":26.2,"low":23.82,"amount":245150059,"amplitude":0.098266,"askPrice":26.1,"askSize":20800,"bidPrice":26.08,"bidSize":7400,"shortable":3,"etf":0,"ttmEps":0.35641299692091827,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":5,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":24.22,"dividendRate":0.001253,"openAndCloseTimeList":[[1767922200000,1767931200000],[1767934800000,1767945600000]],"volumeRatio":1.410132,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":42.11,"timestamp":1767942000000,"preClose":42.18,"halted":0,"volume":22167800,"delay":0,"premium":"-44.49"}},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"2602347895","title":"港股异动 | 昭衍新药(06127)涨超7% 近一月股价累涨近六成 公司有望受益猴价公允价值收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2602347895","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602347895?lang=zh_cn&edition=full","pubTime":"2026-01-09 14:49","pubTimestamp":1767941364,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，昭衍新药再涨超7%，近一月股价累涨近六成。截至发稿，涨7.02%，报25.92港元，成交额2.03亿港元。据方正证券测算，以昭衍新药为例，假设按照2024年实验猴均价计入公允价值8.49万/只，2025Q4价格提升至14万/只，假设猴场出栏率为17%，按照已知23200只猴测算，毛估计2025年新增公允价值约2.2亿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06127","603127","BK1576","BK0216","BK1141"],"gpt_icon":0},{"id":"2601339124","title":"港股异动 | 昭衍新药(06127)再涨超4% 实验猴供需缺口或不断拉大 公司拥有优质稀缺实验猴资源","url":"https://stock-news.laohu8.com/highlight/detail?id=2601339124","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601339124?lang=zh_cn&edition=full","pubTime":"2026-01-08 10:59","pubTimestamp":1767841147,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，昭衍新药再涨超4%，截至发稿，涨3.36%，报24港元，成交额1.08亿港元。长江证券发布研报称，当前，实验猴供给端不断下降，需求端企稳回升以及新技术如小核酸、CAR-T 等大多也需要使用实验猴带来的结构化占比提升，实验猴供需缺口或正不断拉大，猴价也开始呈现上升趋势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","603127","BK0216","BK1141","06127"],"gpt_icon":0},{"id":"1172443975","title":"北京昭衍新药(603127)更新翌日披露报表，注销逾12.9万股库藏股","url":"https://stock-news.laohu8.com/highlight/detail?id=1172443975","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172443975?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:46","pubTimestamp":1767779166,"startTime":"0","endTime":"0","summary":"北京昭衍新药研究中心股份有限公司(603127)于2026年1月7日发布翌日披露报表，公告显示，公司注销了129,114股用于2021年及2022年员工持股计划的库藏股份。注销数量占公司现有已发行股份(不包括库藏股)的比例约0.02%。\n本次注销前，公司已发行股份(不包括库藏股)共627,179,094股，库藏股数量3,303,034股。注销后，库藏股数降至3,173,920股，公司总股本则相应从630,482,128股调整至630,353,014股。公司在公告中确认已经遵守相关上市规则及法律法规，所有相关程序均获正式授权批准。\n该公告由联席公司秘书高大鹏签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"gpt_icon":0},{"id":"2601760808","title":"港股创新药ETF基金涨近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601760808","media":"云掌财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601760808?lang=zh_cn&edition=full","pubTime":"2026-01-07 13:58","pubTimestamp":1767765495,"startTime":"0","endTime":"0","summary":"盘面上，港股创新药表现活跃，凯莱英飙涨7%，泰格医药、昭衍新药、康方生物涨超5%，和黄医药、翰森制药、恒瑞医药等个股涨超4%。截至10：34，热门ETF——港股创新药ETF基金上涨2.85%，冲击三连涨！数据显示，港股创新药ETF基金近60日“吸金”超1亿；最新基金规模达9.39亿元。港股创新药ETF基金跟踪中证港股通创新药指数，指数编制方式更科学合理，成分股涵盖如百济神州、信达生物和药明生物等领军企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107135820a4a649a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107135820a4a649a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","BK1191","00013","02315","01276","BK1161","03692","06127","06821","BK1574","09926","02269","06978"],"gpt_icon":0},{"id":"2601828162","title":"港股异动 | CRO概念股集体走高 行业内外需共振 2026年业绩有望进入改善周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2601828162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601828162?lang=zh_cn&edition=full","pubTime":"2026-01-07 10:41","pubTimestamp":1767753707,"startTime":"0","endTime":"0","summary":"中泰证券认为，CRO、CDMO行业内外需共振，供给端逐步出清。兴业证券指出，受益于创新药BD出海和融资企稳回升，多家CRO新签订单逐季度加速，项目量实现双位数增长。Q4以来从实验用猴、安评报价到临床项目价格均有提升趋势，客户需求保持旺盛，展望2026年CRO业绩有望进入改善周期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","06821","06127","BK1141","LU2125910500.SGD","LU0708995583.HKD","BK1191","02359","LU2045819591.USD","LU1046422090.SGD","03759","LU2242644610.SGD","BK1576","LU0052750758.USD","03347","LU0320764599.SGD"],"gpt_icon":0},{"id":"2601180350","title":"医疗服务板块走高，机构称看好2026年医药板块的行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2601180350","media":"腾讯自选股综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601180350?lang=zh_cn&edition=full","pubTime":"2026-01-07 10:22","pubTimestamp":1767752521,"startTime":"0","endTime":"0","summary":"11月7日，医疗服务板块走高，益诺思涨停，成都先导涨超10%，博济医药、药康生物、昭衍新药、皓元医药、阳光诺和等跟涨。中泰证券认为，医药板块阶段的修整是为了2026 年更好的行情沉淀，消化一些过高的预期以及筹码，同时等待JPM、ASCO 等2026 年重要节点的数据或是交易的催化，看好2026 年医药板块的行情，建议积极寻找调整后的优质创新药标的，同时看好创新药产业链CXO 的复苏持续改善，并建议关注医疗器械、医疗服务等板块的困境反转的机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107101454a4a58f16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107101454a4a58f16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1161","BK1515","09939","BK1574","BK1141"],"gpt_icon":0},{"id":"2601840970","title":"CRO指数震荡走高，成分股普涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2601840970","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601840970?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:55","pubTimestamp":1767750953,"startTime":"0","endTime":"0","summary":"每经AI快讯，1月7日，CRO指数震荡走高，成分股呈现普涨态势。成都先导涨逾10%，益诺思涨7.70%，昭衍新药涨4.94%，美迪西涨2.82%，阳光诺和涨2.72%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601073611186027.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601073611186027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2601180738","title":"昭衍新药（603127）披露员工持股计划回购股份注销实施公告，1月6日股价下跌0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601180738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601180738?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:09","pubTimestamp":1767708560,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，昭衍新药报收于38.45元，较前一交易日下跌0.16%，最新总市值为288.17亿元。该股当日开盘39.8元，最高39.96元，最低37.8元，成交额达13.08亿元，换手率为5.37%。公司近日发布公告称，北京昭衍新药研究中心股份有限公司因终止实施2021年及2022年A股员工持股计划，拟注销回购专用账户中合计129,114股A股股份。该事项已履行董事会、股东大会审议程序，并完成债权人通知程序。本次注销股份将于2026年1月7日实施，公司总股本将由749,477,334股变更为749,348,220股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","06127","603127","BK0216","BK1141"],"gpt_icon":0},{"id":"2601002067","title":"昭衍新药（603127）披露H股及A股股本无变动情况，1月5日股价上涨10.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601002067","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601002067?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:42","pubTimestamp":1767606170,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，昭衍新药报收于38.51元，较前一交易日上涨10.0%，最新总市值为288.62亿元。公司近日发布公告称，北京昭衍新药研究中心股份有限公司已提交截至2025年12月31日的证券变动月报表。公告显示，公司H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股于香港联交所上市，证券代码06127；A股于上海证券交易所上市，证券代码603127。已发行H股118,995,206股，A股627,179,094股，库存股3,303,034股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500025712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0216","BK1141","159982","399300","603127","06127"],"gpt_icon":0},{"id":"2601545853","title":"每日卖空追踪 | 昭衍新药 01月05日卖空量成交49.84万股，卖空比例为6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601545853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601545853?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601836,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间01月05日，涨13.73%，卖空量成交49.84万股，较上一交易日增加401.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163745a6f52728&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163745a6f52728&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1141","BK1576"],"gpt_icon":0},{"id":"2601453071","title":"港股异动 | CRO概念股表现强势 外需修复已明确兑现至业绩 内需复苏自前端衍生至后端","url":"https://stock-news.laohu8.com/highlight/detail?id=2601453071","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601453071?lang=zh_cn&edition=full","pubTime":"2026-01-05 11:20","pubTimestamp":1767583222,"startTime":"0","endTime":"0","summary":"华福证券发布研报称，外需CXO企业自24年订单已经显著改善，业绩上24Q4便恢复同比增长并延续至25Q3，行业触底反弹趋势已经明确，我们认为外需CXO 26年有望延续25年的上行趋势；内需CXO 25年初以来在业绩及股价表现相对外需较为弱势，行业整体复苏滞后，但从前端延续至后端确定性较强，当前或处于左侧机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2045819591.USD","BK1141","BK1583","02359","LU0320764599.SGD","LU2242644610.SGD","LU0708995583.HKD","LU1046422090.SGD","03347","LU2125910500.SGD","BK1576","06127","03759","LU0052750758.USD"],"gpt_icon":0},{"id":"2601797130","title":"异动快报：昭衍新药（603127）1月5日10点53分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601797130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601797130?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:55","pubTimestamp":1767581719,"startTime":"0","endTime":"0","summary":"证券之星1月5日盘中消息，10点53分昭衍新药触及涨停板。其所属行业医疗服务目前上涨。领涨股为三博脑科。该股为基因编辑，干细胞，AI医疗概念热股，当日基因编辑概念上涨4.47%，干细胞概念上涨4.05%，AI医疗概念上涨3.75%。12月31日的资金流向数据方面，主力资金净流出5814.26万元，占总成交额9.85%，游资资金净流入1665.91万元，占总成交额2.82%，散户资金净流入4148.35万元，占总成交额7.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500008901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","603127","BK1576","BK1141","BK0216"],"gpt_icon":0},{"id":"2601793240","title":"港股医药股走强 昭衍新药涨近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601793240","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601793240?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:24","pubTimestamp":1767579852,"startTime":"0","endTime":"0","summary":"南方财经1月5日电，港股医药股走强，截至发稿，昭衍新药(06127.HK)涨9.72%、泰格医药(03347.HK)涨5.94%、康龙化成(03759.HK)涨3.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601053608528139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","BK0216","BK1141","603127","06127","159718"],"gpt_icon":0},{"id":"2600842035","title":"每周股票复盘：昭衍新药（603127）实控人周志文拟减持不超1.99873%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600842035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600842035?lang=zh_cn&edition=full","pubTime":"2026-01-02 01:23","pubTimestamp":1767288189,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，昭衍新药报收于36.94元，较上周的35.42元上涨4.29%。本周，昭衍新药12月25日盘中最高价报37.89元。12月22日盘中最低价报34.46元。昭衍新药当前最新总市值262.39亿元，在医疗服务板块市值排名6/51，在两市A股市值排名753/5181。减持原因为自身资金需求，减持价格将根据市场价格确定。本次减持不会导致公司控制权变更，且符合相关法律法规及此前承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","06127","BK1576","603127","BK1141"],"gpt_icon":0},{"id":"2595113637","title":"昭衍新药实控人周志文拟减持不超1.99873%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2595113637","media":"中访网数据","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595113637?lang=zh_cn&edition=full","pubTime":"2025-12-30 18:00","pubTimestamp":1767088800,"startTime":"0","endTime":"0","summary":"中访网数据北京昭衍新药研究中心股份有限公司于2025年12月30日晚间发布股东减持股份计划公告。公司实际控制人之一周志文计划自公告之日起15个交易日后的3个月内，通过集中竞价或大宗交易方式减持其持有的公司股份。本次拟减持股份数量不超过14,980,000股，占其个人持股总数的20.0466%，占公司总股本的比例不超过1.99873%。减持股份来源于公司首发前股份及资本公积金转增股份等，减持原因为股东自身资金需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230180300a6e0d91f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230180300a6e0d91f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","06127"],"gpt_icon":0},{"id":"2595711354","title":"每日卖空追踪 | 昭衍新药 12月30日卖空量成交14.89万股，卖空比例为1.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595711354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595711354?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083435,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间12月30日，跌5.45%，卖空量成交14.89万股，较上一交易日减少75.4%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163608a6e07f54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163608a6e07f54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2595762310","title":"12月30日昭衍新药跌6.20%，广发小盘LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595762310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595762310?lang=zh_cn&edition=full","pubTime":"2025-12-30 15:32","pubTimestamp":1767079952,"startTime":"0","endTime":"0","summary":"证券之星消息，12月30日昭衍新药跌6.20%，收盘报34.8元，换手率5.23%，成交量33.0万手，成交额11.47亿元。重仓昭衍新药的前十大公募基金请见下表：该股最近90天内共有6家机构给出评级，买入评级5家，增持评级1家；过去90天内机构目标均价为40.13。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共19家，其中持有数量最多的公募基金为广发基金的广发小盘LOF。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000020196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","162703","603127","06127","BK0216"],"gpt_icon":0},{"id":"2595662547","title":"港股创新药板块午后持续走弱，昭衍新药跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595662547","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595662547?lang=zh_cn&edition=full","pubTime":"2025-12-30 13:15","pubTimestamp":1767071744,"startTime":"0","endTime":"0","summary":"每经AI快讯，12月30日，港股创新药板块午后持续走弱，昭衍新药跌超7%，荣昌生物、康龙化成、歌礼制药-B跌超5%，凯莱英、诺诚健华跟跌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512303605538957.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512303605538957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK0216","BK1574","06127","BK1576","603127","BK1141","06978","159992"],"gpt_icon":0},{"id":"2595678941","title":"昭衍新药实控人之一周志文计划减持不超近2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2595678941","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595678941?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:50","pubTimestamp":1767001821,"startTime":"0","endTime":"0","summary":"12月29日，昭衍新药（603127/06127）发布公告，实际控制人之一周志文因自身资金需求，计划自2026年1月22日至2026年4月21日，通过集中竞价和大宗交易方式减持不超过1498万股，占公司总股本的1.99873%。2025年前三季度，昭衍新药实现收入9.85亿元，归母净利润8071万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512293604528115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK1576","BK0216","06127","603127"],"gpt_icon":0},{"id":"2595759308","title":"每日卖空追踪 | 昭衍新药 12月29日卖空量成交44.64万股，卖空比例为9.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595759308","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595759308?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:30","pubTimestamp":1766997034,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间12月29日，跌2.4%，卖空量成交44.64万股，较上一交易日增加139.87%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163538a6dc4b04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163538a6dc4b04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1757},{"period":"1month","weight":0.4081},{"period":"3month","weight":0.2086},{"period":"6month","weight":0.1616},{"period":"1year","weight":1.8785},{"period":"ytd","weight":0.1757}],"compareEarnings":[{"period":"1week","weight":0.0202},{"period":"1month","weight":0.0281},{"period":"3month","weight":-0.0054},{"period":"6month","weight":0.0833},{"period":"1year","weight":0.3563},{"period":"ytd","weight":0.0202}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.053803},{"month":2,"riseRate":0.75,"avgChangeRate":0.137943},{"month":3,"riseRate":0.4,"avgChangeRate":-0.007614},{"month":4,"riseRate":0.2,"avgChangeRate":-0.110118},{"month":5,"riseRate":0.8,"avgChangeRate":0.111301},{"month":6,"riseRate":0.6,"avgChangeRate":0.067356},{"month":7,"riseRate":0.8,"avgChangeRate":0.10434},{"month":8,"riseRate":0,"avgChangeRate":-0.152531},{"month":9,"riseRate":0.6,"avgChangeRate":0.016217},{"month":10,"riseRate":0.2,"avgChangeRate":-0.062992},{"month":11,"riseRate":0.4,"avgChangeRate":0.019594},{"month":12,"riseRate":0.6,"avgChangeRate":0.001916}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}